TAF9 and synovial sarcoma: SLE sera (37.4% and 30.7%) exhibited the highest seropositive rate for anti-CMVpp65 IgG and anti-TAF9 IgG when compared to the sera from AS (32.7% and 11.5%) and SS (18.8% and 20.3%; Table 1).